| Symbol | RGEN |
|---|---|
| Name | REPLIGEN CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 41 SEYON STREET, WALTHAM, MA 02453 |
| Telephone | 7814499560 |
| Fax | — |
| — | |
| Website | https://www.repligen.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000730272 |
| Description | Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The companys customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the companys revenue is generated in North America. Additional info from NASDAQ: |
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Read moreDirector Loeillot Olivier 🟡 adjusted position in 5.4K shares (1 derivative) of REPLIGEN CORP (RGEN) at $180.00 ($2.5M) Transaction Date: Aug 20, 2026 | Filing ID: 058417
Read more📋 Loeillot Olivier (Officer) plans to sell 5K shares of REPLIGEN CORP (at $180.00 each, total $977K) Filed: Aug 20, 2026 | ID: 006257
Read moreRepligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Read moreNew Form 425 - REPLIGEN CORP <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001193125-26-311411 <b>Size:</b> 2 MB
Read moreRepligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Read moreGarland Jason K 🔴 sold 530 shares of REPLIGEN CORP (RGEN) at $150.00 Transaction Date: Jul 16, 2026 | Filing ID: 307925
Read more📋 Garland Jason K (Officer) plans to sell 530 shares of REPLIGEN CORP (at $150.00 each, total $80K) Filed: Jul 16, 2026 | ID: 005250
Read more